Aldurazyme laronidase: Completed Phase III study enrollment

BioMarin Pharmaceutical Inc. (BMRN; SWX:BMRN), Novato, Calif.
Product:

Read the full 82 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE